Breaking News Instant updates and real-time market news.

TODAY'S FREE FLY STORIES

Hot Stocks
Auxly Cannabis enters supply agreement with Delta 9 Cannabis » 07:59
02/25/20
02/25
07:59
02/25/20
07:59
CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

, VRNDF

Delta 9 Cannabis

$0.00 /

+ (+0.00%)

Auxly Cannabis Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
SVB Leerink to hold a conference » 07:58
02/25/20
02/25
07:58
02/25/20
07:58
ABBV

AbbVie

$93.14 /

-1.82 (-1.92%)

, BBIO

BridgeBio

$33.25 /

-2.84 (-7.87%)

, CYAD

Celyad

$9.95 /

-0.41 (-3.96%)

, DCPH

Deciphera

$53.80 /

-1.25 (-2.27%)

, FULC

Fulcrum Therapeutics

$16.31 /

-3.01 (-15.58%)

, GH

Guardant Health

$84.09 /

-4.85 (-5.45%)

, IMVT

Immunovant

$14.80 /

-0.71 (-4.58%)

, INGN

Inogen

$43.50 /

-0.64 (-1.45%)

, LMAT

LeMaitre

$30.10 /

-0.27 (-0.89%)

, NUAN

Nuance

$22.83 /

-0.37 (-1.59%)

, NVCN

Neovasc

$2.87 /

-0.16 (-5.28%)

, RARE

Ultragenyx

$57.09 /

-2.3 (-3.87%)

, QURE

uniQure

$58.38 /

-2.52 (-4.14%)

, SELB

Selecta Biosciences

$4.22 /

-0.02 (-0.47%)

, VCEL

Vericel

$18.93 /

-0.315 (-1.64%)

, RDUS

Radius Health

$18.98 /

-0.37 (-1.91%)

, PODD

Insulet

$207.49 /

-4.82 (-2.27%)

, RDHL

RedHill Biopharma

$4.71 /

-0.18 (-3.68%)

, TCRR

TCR2 Therapeutics

$13.68 /

-0.32 (-2.29%)

, ORGO

Organogenesis

$4.50 /

-0.35 (-7.22%)

, OSMT

Osmotica Pharmaceuticals

$5.59 /

-0.24 (-4.12%)

, MLND

Millendo Therapeutics

$9.47 /

+0.5 (+5.57%)

, ITCI

Intra-Cellular

$23.05 /

-1.63 (-6.60%)

, IFRX

InflaRx

$4.25 /

-0.31 (-6.80%)

, STSA

Satsuma Pharmaceuticals

$26.54 /

-2.21 (-7.69%)

, MIRM

Mirum Pharmaceuticals

$18.34 /

+1.61 (+9.62%)

9th Annual Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Clovis initiated with an Outperform at RBC Capital » 07:58
02/25/20
02/25
07:58
02/25/20
07:58
CLVS

Clovis

$9.92 /

-1.07 (-9.74%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Zynerba receives U.S. patent for treatment of ASD with cannabidiol » 07:58
02/25/20
02/25
07:58
02/25/20
07:58
ZYNE

Zynerba

$4.64 /

-0.29 (-5.88%)

Zynerba Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Merit Medical price target raised to $47 from $43 at Raymond James » 07:57
02/25/20
02/25
07:57
02/25/20
07:57
MMSI

Merit Medical

$38.86 /

-0.795 (-2.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Marinus Pharmaceuticals completes enrollment in Phase 3 study of ganaxolone » 07:56
02/25/20
02/25
07:56
02/25/20
07:56
MRNS

Marinus Pharmaceuticals

$2.86 /

+0.01 (+0.35%)

Marinus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
EverQuote price target raised to $48 from $38 at Canaccord » 07:55
02/25/20
02/25
07:55
02/25/20
07:55
EVER

EverQuote

$45.76 /

-0.83 (-1.78%)

Canaccord analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Oneok sees 20% increase in adjusted EBITDA in 2021 vs. 2020 view midpoint » 07:54
02/25/20
02/25
07:54
02/25/20
07:54
OKE

Oneok

$75.07 /

-1.98 (-2.57%)

ONEOK announced last…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Opera sees Q1 revenue $123M-$133M » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
OPRA

Opera

$7.14 /

+0.275 (+4.01%)

Sees Adjusted EBITDA of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Wells Fargo to hold a conference » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
MTH

Meritage Homes

$71.88 /

-0.73 (-1.01%)

, NHI

National Health Investors

$90.58 /

-0.15 (-0.17%)

23rd Annual Real Estate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Orthofix price target lowered to $42 from $48 at Cantor Fitzgerald » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
OFIX

Orthofix

$44.90 /

-0.03 (-0.07%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
ChemoCentryx price target raised to $64 from $48 at Canaccord » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
CCXI

ChemoCentryx

$47.01 /

-1.84 (-3.77%)

Canaccord analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Opera sees FY20 revenue $530M-$560M, consensus $411.34M » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
OPRA

Opera

$7.14 /

+0.275 (+4.01%)

Mr. Frode Jacobsen,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Wedbush to hold a forum » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
AX

Axos Financial

$26.96 /

-1.12 (-3.99%)

, CATY

Cathay General

$35.13 /

-1.12 (-3.09%)

, EWBC

East West Bancorp

$43.43 /

-2.64 (-5.73%)

, FFWM

First Foundation

$16.04 /

-0.55 (-3.32%)

, HAFC

Hanmi Financial

$17.28 /

-0.35 (-1.99%)

, HMST

HomeStreet

$30.64 /

-0.56 (-1.79%)

, HOPE

Hope Bancorp

$13.84 /

-0.305 (-2.16%)

, PACW

PacWest Bancorp

$35.57 /

-0.84 (-2.31%)

, PFSI

PennyMac Financial

$35.74 /

+0.27 (+0.76%)

, PMT

PennyMac Mortgage

$22.96 /

-0.38 (-1.63%)

, TSC

TriState Capital

$22.05 /

-0.53 (-2.35%)

, UMPQ

Umpqua Holdings

$17.29 /

-0.47 (-2.65%)

, WAL

Western Alliance

$53.35 /

-2.565 (-4.59%)

2020 West Coast Bank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Oneok sees FY20 EPS $3.25-$3.85, consensus $3.85 » 07:52
02/25/20
02/25
07:52
02/25/20
07:52
OKE

Oneok

$75.07 /

-1.98 (-2.57%)

Last night, Terry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Opera reports Q4 adj. EPS 20c, two est. 9c » 07:52
02/25/20
02/25
07:52
02/25/20
07:52
OPRA

Opera

$7.14 /

+0.275 (+4.01%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Cantor reiterates Overweight rating on Theravance into 'big year' » 07:51
02/25/20
02/25
07:51
02/25/20
07:51
TBPH

Theravance Biopharma

$23.51 /

-2.2 (-8.56%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Dine Brands downgraded to Neutral from Buy at MKM Partners » 07:50
02/25/20
02/25
07:50
02/25/20
07:50
DIN

Dine Brands

$96.06 /

-1.13 (-1.16%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Xencor upgraded to Buy from Neutral at Guggenheim » 07:50
02/25/20
02/25
07:50
02/25/20
07:50
XNCR

Xencor

$33.21 /

-1.93 (-5.49%)

Guggenheim analyst Etzer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
NIO Inc. announces framework agreement with Hefei Municipal Government » 07:49
02/25/20
02/25
07:49
02/25/20
07:49
NIO

NIO Inc.

$3.88 /

-0.195 (-4.79%)

NIO announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Galapagos downgraded to Neutral on valuation at Cantor Fitzgerald » 07:49
02/25/20
02/25
07:49
02/25/20
07:49
GLPG

Galapagos

$245.02 /

-28.77 (-10.51%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Palo Alto Networks price target lowered to $190 from $195 at Credit Suisse » 07:48
02/25/20
02/25
07:48
02/25/20
07:48
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Corvus Gold receives results from Main Zone infill, step-out Phase-4 program » 07:48
02/25/20
02/25
07:48
02/25/20
07:48
CORVF

Corvus Gold

$0.00 /

+ (+0.00%)

Corvus Gold announces it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Tandem Diabetes price target raised to $90 from $85 at Cowen » 07:47
02/25/20
02/25
07:47
02/25/20
07:47
TNDM

TNDM

/

+

Cowen analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Arcutis Biotherapeutics initiated with an Overweight at Cantor Fitzgerald » 07:46
02/25/20
02/25
07:46
02/25/20
07:46
ARQT

Arcutis Biotherapeutics

$28.04 /

+1.035 (+3.83%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.